CD34+ Cell-Derived Fibroblast-Macrophage Cross-Talk Drives Limb Ischemia Recovery Through the OSM-ANGPTL Signaling Axis
April 2023
in “
Science Advances
”
Studysummary This study identified that bone marrow-derived CD34<sup>+</sup> cells act as fibroblast progenitors to enhance tissue regeneration in ischemic limbs by promoting angiogenesis through interactions with macrophages.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on science.org →